Browse by ["viewname_eprint_publisher" not defined]

A

Altenbuchinger, M. and Rehberg, T. and Zacharias, H. U. and Staemmler, F. and Dettmer, K. and Weber, D. and Hiergeist, A. and Gessner, A. and Holler, E. and Oefner, P. J. and Spang, R. (2017) Reference point insensitive molecular data analysis. BIOINFORMATICS, 33 (2). pp. 219-226. ISSN 1367-4803, 1460-2059

Altmannsberger, Philipp and Holler, Ernst and Andreesen, Reinhard and Krause, Stefan W. (2007) Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 60 (1). pp. 180-182. ISSN 0305-7453

B

Bross, K. and Berand, A. and Reichle, A. and Demandt, M. and Fischer von Weikersthal, L. and Funk, R. and Andreesen, R. (2005) Fludarabine phosphate and cyclophosphamide combined with immunotherapy (rituximab) once weekly is safe and highly effective in older patients with indolent B-NHL. In: 9th International Conference on Malignant Lymphoma, June 09-11, 2005, Lugano, Switzerland.

Bross, K. and Berand, A. and Reichle, A. and Demandt, M. and Fischer von Weikersthal, L. and Funk, R. and Andreesen, R. (2005) Fludarabine phosphate and cyclophosphamide combined with immunotherapy (rituximab) once weekly is safe and highly effective in patients with indolent B-cell malignancies. In: 9th International Conference on Malignant Lymphoma, June 09-11, 2005, Lugano, Switzerland.

E

Eissner, Guenther and Hartmann, Isabel and Kesikli, Altug and Holler, Ernst and Haffner, Silvia and Sax, Tanja and Schray, Carolin and Meiser, Bruno and Reichart, Bruno (2011) CD4+CD25+FoxP3+regulatory T cells enhance the allogeneic activity of endothelial-specific CD8+/CD28-CTL. INTERNATIONAL IMMUNOLOGY, 23 (8). pp. 485-492. ISSN 0953-8178

F

Fan, Kaiji and Srinivas, Nalini and Kubat, Linda and Gravemeyer, Jan and Sucker, Antje and Schadendorf, Dirk and Gambichler, Thilo and Becker, Juergen C. (2023) B-cell lymphoma-extra large is a promising drug target in Merkel cell carcinoma. BRITISH JOURNAL OF DERMATOLOGY, 189 (1). pp. 103-113. ISSN 0007-0963, 1365-2133

Fenk, S. and Mueller, S. and Wallner, S. and Strack, C. and Hubauer, U. and Mohr, M. and Zeller, J. and Rehli, M. and Loew, T. and Maier, L. S. and Fischer, M. and Baessler, A. (2018) The cardiometabolic consequences of obesity susceptibility gene variants in severe obesity. OXFORD UNIV PRESS, OXFORD.

G

Gebhard, Claudia and Schwarzfischer, Lucia and Pham, Thu Hang and Andreesen, Reinhard and Mackensen, Andreas and Rehli, Michael (2006) Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR. NUCLEIC ACIDS RESEARCH, 34 (11): e82. ISSN 0305-1048

Glasmacher, Axel and Cornely, Oliver and Ullmann, Andrew J. and Wedding, Ulrich and Bodenstein, Heinrich and Wandt, Hannes and Boewer, Christian and Pasold, Rita and Wolf, Hans-Heinrich and Haenel, Matthias and Dolken, Gottfried and Junghanss, Christian and Andreesen, Reinhard and Bertz, Hartmut (2006) An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 57 (2). pp. 317-325. ISSN 0305-7453

Godecke, Natascha and Zha, Lisha and Spencer, Shawal and Behme, Sara and Riemer, Pamela and Rehli, Michael and Hauser, Hansjoerg and Wirth, Dagmar (2017) Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylation. NUCLEIC ACIDS RESEARCH, 45 (16): e147. ISSN 0305-1048, 1362-4962

Goekbuget, N. and Topp, M. S. and Zugmaier, G. and Viardot, A. and Stelljes, M. and Neumann, S. and Horst, H. and Reichle, A. and Marks, R. and Brueggemann, M. and Ritgen, M. and Klappers, P. and Mergen, N. and Goebeler, M. E. and Einsele, H. and Hoelzer, D. and Bargou, R. (2012) ANTI-CD19 BITE BLINATUMOMAB INDUCES HIGH COMPLETE REMISSION RATE IN ADULT PATIENTS WITH RELAPSED B-PRECURSOR ALL: UPDATED RESULTS OF AN ONGOING PHASE II TRIAL. ANNALS OF ONCOLOGY, 23 (Suppl1). i20-i21. ISSN 0923-7534

Grauer, Oliver and Wolff, Daniel and Bertz, Hartmut and Greinix, Hildegard and Kuehl, Joern-Sven and Lawitschka, Anita and Lee, Stephanie J. and Pavletic, Steven Z. and Holler, Ernst and Kleiter, Ingo (2010) Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. BRAIN, 133 (10). pp. 2852-2865. ISSN 0006-8950

Grube, Matthias and Loeffler, Juergen and Mezger, Markus and Krueger, Bernd and Echtenacher, Bernd and Hoffmann, Petra and Edinger, Matthias and Einsele, Hermann and Andreesen, Reinhard and Holler, Ernst (2013) TLR5 stop codon polymorphism is associated with invasive aspergillosis after allogeneic stem cell transplantation. MEDICAL MYCOLOGY, 51 (8). pp. 818-825. ISSN 1369-3786, 1460-2709

H

Heidemann, E. and Stoeger, H. and Souchon, R. and Hirschmann, W. D. and Bodenstein, H. and Oberhoff, C. and Fischer, J. T. and Schulze, M. and Clemens, M. and Andreesen, R. and Mahlke, M. and Koenig, M. and Scharl, A. and Fehnle, K. and Kaufmann, M. (2002) Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial. ANNALS OF ONCOLOGY, 13 (11). pp. 1717-1729. ISSN 0923-7534

Heudobler, D. and Schulz, C. and Fischer, J. R. and Staib, P. and Wehler, T. and Suedhoff, T. and Schichtl, T. and Wilke, J. and Hahn, J. and Lueke, F. and Vogelhuber, M. and Klobuch, S. and Pukrop, T. and Herr, W. and Held, S. and Beckers, K. and Bouche, G. and Reichle, A. (2019) Pioglitazone and clarithromycin combined with metronomic low-dose chemotherapy versus nivolumab in patients with advanced non-small cell lung cancer treated in 2nd-line and beyond: Outcomes from a randomized phase II trial (ModuLung). OXFORD UNIV PRESS, OXFORD.

J

Janker, Lukas and Schuster, Dina and Bortel, Patricia and Hagn, Gerhard and Meier-Menches, Samuel M. and Mohr, Thomas and Mader, Johanna C. and Slany, Astrid and Bileck, Andrea and Brunmair, Julia and Madl, Christian and Unger, Lukas and Hennlich, Barbara and Weitmayr, Barbara and Del Favero, Giorgia and Pils, Dietmar and Pukrop, Tobias and Pfisterer, Nikolaus and Feichtenschlager, Thomas and Gerner, Christopher (2023) Multiomics-empowered Deep Phenotyping of Ulcerative Colitis Identifies Biomarker Signatures Reporting Functional Remission States. JOURNAL OF CROHNS & COLITIS, 17 (9). pp. 1514-1527. ISSN 1873-9946, 1876-4479

K

Kallinger, Isabella and Rubenich, Dominique S. and Gluszko, Alicja and Kulkarni, Aditi and Spanier, Gerrit and Spoerl, Steffen and Taxis, Juergen and Poeck, Hendrik and Szczepanski, Miroslaw J. and Ettl, Tobias and Reichert, Torsten E. and Meier, Johannes K. and Braganhol, Elizandra and Ferris, Robert L. and Whiteside, Theresa L. and Ludwig, Nils (2023) Tumor gene signatures that correlate with release of extracellular vesicles shape the immune landscape in head and neck squamous cell carcinoma. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 213 (1). pp. 102-113. ISSN 0009-9104, 1365-2249

Kawaji, Hideya and Severin, Jessica and Lizio, Marina and Forrest, Alistair R. R. and van Nimwegen, Erik and Rehli, Michael and Schroder, Kate and Irvine, Katharine and Suzuki, Harukazu and Carninci, Piero and Hayashizaki, Yoshihide and Daub, Carsten O. (2011) Update of the FANTOM web resource: from mammalian transcriptional landscape to its dynamic regulation. NUCLEIC ACIDS RESEARCH, 39. D856-D860. ISSN 0305-1048

Knoedler, M. K. and Gauler, T. C. and Matzdorff, A. and Jordan, O. and Schroeder, M. and Gruenwald, V. and Dietz, A. and Hennemann, B. and Arnold, D. and Keilholz, U. (2008) CETUXIMAB PLUS DOCETAXEL AS TREATMENT FOR RECURRENT AND/OR METASTATIC HEAD AND NECK CANCER. In: 33rd European Society for Medical Oncology Congress, September 12-16, 2008, Stockholm, Sweden.

T

Thiel, U. and Wawer, A. and Wolf, P. and Badoglio, M. and Santucci, A. and Klingebiel, T. and Basu, O. and Borkhardt, A. and Laws, H. -J. and Kodera, Y. and Yoshimi, A. and Peters, C. and Ladenstein, R. and Pession, A. and Prete, A. and Urban, E. -C. and Schwinger, W. and Bordigoni, P. and Salmon, A. and Diaz, M. A. and Afanasyev, B. and Lisukov, I. and Morozova, E. and Toren, A. and Bielorai, B. and Korsakas, J. and Fagioli, F. and Caselli, D. and Ehninger, G. and Gruhn, B. and Dirksen, U. and Abdel-Rahman, F. and Aglietta, M. and Mastrodicasa, E. and Torrent, M. and Corradini, P. and Demeocq, F. and Dini, G. and Dreger, P. and Eyrich, M. and Gozdzik, J. and Guilhot, F. and Holler, E. and Koscielniak, E. and Messina, C. and Nachbaur, D. and Sabbatini, R. and Oldani, E. and Ottinger, H. and Ozsahin, H. and Schots, R. and Siena, S. and Stein, J. and Sufliarska, S. and Unal, A. and Ussowicz, M. and Schneider, P. and Woessmann, W. and Juergens, H. and Bregni, M. and Burdach, S. (2011) No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. ANNALS OF ONCOLOGY, 22 (7). pp. 1614-1621. ISSN 0923-7534, 1569-8041

Thu-Hang Pham, and Minderjahn, Julia and Schmidl, Christian and Hoffmeister, Helen and Schmidhofer, Sandra and Chen, Wei and Laengst, Gernot and Benner, Christopher and Rehli, Michael (2013) Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1. NUCLEIC ACIDS RESEARCH, 41 (13). pp. 6391-6402. ISSN 0305-1048, 1362-4962

V

von Schilling, C. and Schwarz, K. and Hess, G. and Thoennissen, J. and Viardot, A. and Sandherr, M. and Krause, S. and Simons, J. and Peschel, C. and Scheidhauer, K. (2008) 90-yttrium-ibritumomab tiuxetan consolidation following 3 cycles of FC-R in elderly patients with relapsed lymphoma: A dose-finding study. ANNALS OF ONCOLOGY, 19 (Suppl4). iv208. ISSN 0923-7534

W

Weidmann, E. and Hess, G. and Krause, S. and Hebart, H. and Dreyling, M. and Subklewe, M. and Falge, C. and Atmaca, A. and Jaeger, E. and Mitrou, P. (2005) Alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (campath-FCD): An effective first-line treatment in peripheral T-cell lymphomas. In: 9th International Conference on Malignant Lymphoma, June 09-11, 2005, Lugano, Switzerland.

Weil, Tobias and Korb, Judith and Rehli, Michael (2009) Comparison of Queen-Specific Gene Expression in Related Lower Termite Species. MOLECULAR BIOLOGY AND EVOLUTION, 26 (8). pp. 1841-1850. ISSN 0737-4038